Article info
PDFMiscellaneous
Oral gefitinib produces symptomatic and radiological benefit in advanced NSCLC
Citation
Oral gefitinib produces symptomatic and radiological benefit in advanced NSCLC
Publication history
- First published February 3, 2004.
Online issue publication
September 01, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2004 Thorax